Acadia Pharmaceuticals (ACAD) Tops Q1 Earnings Estimates
ACADACADIA Pharmaceuticals(ACAD) Zacks Investment Research·2024-05-09 06:16

Acadia Pharmaceuticals (ACAD) came out with quarterly earnings of 0.10pershare,beatingtheZacksConsensusEstimateof0.10 per share, beating the Zacks Consensus Estimate of 0.04 per share. This compares to loss of 0.27pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof1500.27 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 150%. A quarter ago, it was expected that this drugmaker would post earnings of 0.32 per share when it actually produced earnings of $0.28, delivering a surprise of -12.50%. Over the last four quarters, the co ...